ALLE
32
-5
UNP
36
3
MSI
32
-11
FRT
46
5
STT
65
6
MDT
57
-2
APA
46
-3
SYF
62
5
RF
61
4
HAL
37
-6
OKE
40
-2
SCHW
61
2
CAT
46
4
SJM
6
4
NUE
44
4
HBI
43
10
HSY
32
-3
EFX
41
-2
CTAS
50
-2
CA
9
-12
ALLE
32
-5
UNP
36
3
MSI
32
-11
FRT
46
5
STT
65
6
MDT
57
-2
APA
46
-3
SYF
62
5
RF
61
4
HAL
37
-6
OKE
40
-2
SCHW
61
2
CAT
46
4
SJM
6
4
NUE
44
4
HBI
43
10
HSY
32
-3
EFX
41
-2
CTAS
50
-2
CA
9
-12
Financhill
Back

OptimizeRx Stock Predictions

Notable investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
25

OPRX
OptimizeRx

Last Price:
$13.03
Seasonality Move:
-0.35%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

OptimizeRx Stock Forecast

  • Over the next 52 weeks, OptimizeRx has on average historically risen by 18.9% based on the past 19 years of stock performance.
  • OptimizeRx has risen higher in 8 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.11%
  • Is OptimizeRx Stock Undervalued?
    The current OptimizeRx [OPRX] share price is $13.09. The Score for OPRX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • OPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will OptimizeRx Stock Go Up Next Year?

  • Over the next 52 weeks, OptimizeRx has on average historically risen by 18.9% based on the past 19 years of stock performance.

OptimizeRx Stock Rating

Sell
25
OptimizeRx (OPRX) is a Sell

Is OptimizeRx overpriced?

  • OptimizeRx has risen higher in 8 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.11%

OptimizeRx Stock Price History

Is OPRX stock going to rise?

  • The current trend is moderately bearish and OPRX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Technology
Sector:
Health Care
Type:
stock
Website:
optimizerx.com

52-Week Data

52-Week High:
15.71
52-Week Low:
3.78

Prediction Charts

Market Cap:
242.1M
Price in USD:
13.09
Volume:
290.6K
Beta:
0.76

Technical Analysis

SMA50:
10.93
SMA100:
8.74
SMA200:
7.36
52-Wk Change:
20.98%

Stock Predictions

  • Is OptimizeRx stock public?
    Yes, OptimizeRx is a publicly traded company.
  • What is the OptimizeRx stock quote today?
    The OptimizeRx stock price is 13.09 USD today.
  • How to buy OptimizeRx stock online?
    You can buy OptimizeRx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 12.00 12.14 12.27 11.75
Jun-2 12.15 12.35 12.64 12.00
Jun-3 12.69 13.22 13.44 12.01
Jun-4 13.22 13.78 14.01 12.97
Jun-5 13.78 14.18 15.14 13.38
Jun-6 14.44 14.62 15.25 13.54
Jun-9 15.06 14.76 15.20 14.16
Jun-10 14.88 15.44 15.63 14.51
Jun-11 15.50 15.20 15.63 15.08
Jun-12 14.78 15.05 15.71 14.78
Jun-13 14.75 14.27 15.01 14.23
Jun-16 14.29 13.77 14.49 13.68
Jun-17 13.67 13.40 14.01 13.34
Jun-18 13.42 13.09 13.42 12.73

OptimizeRx Earnings

OptimizeRx Earnings Report: Per Share OptimizeRx Earnings Q1 Q2 Q3 and Q4 last year and next year.

OptimizeRx Forecast Revenue Growth

OptimizeRx Stock Analysis: Historical quarterly revenues per share for OptimizeRx and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.11 per share.

* OptimizeRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.